DOSSIER · 13F Holders · Q1 2026Defensive growthQuality
ESPR
Esperion Therapeutics Inc
214 institutions still hold Esperion Therapeutics Inc as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 29664w105·214 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
214 institutions reported ESPR in Q1 2026. BlackRock, Inc. leads at 12.5% of the visible book. +104 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 11
194 more holders available. Log in →